SEC Company Response from Stealth BioTherapeutics Corp (CIK 0001696396) — Apr 8, 2020
Stealth BioTherapeutics Corp (CIK 0001696396)
Date: April 8, 2020 · CIK: 0001696396 · Accession: 0001193125-20-101261
AI Filing Summary & Sentiment
File numbers found in text: 333-237542
Letter
STEALTH BIOTHERAPEUTICS CORP
c/o Intertrust Corporate Services (Cayman) Limited
190 Elgin Avenue
George Town, Grand Cayman
KY1-9005 Cayman Islands
April 8, 2020
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Stealth BioTherapeutics Corp
Registration Statement on Form F-3
File No. 333-237542
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (File No. 333-237542), so that it may become effective at 4:00 p.m., Eastern time, on April 10, 2020, or as soon as practicable thereafter.
Very truly yours,
STEALTH BIOTHERAPEUTICS CORP
Show Raw Text
CORRESP 1 filename1.htm CORRESP STEALTH BIOTHERAPEUTICS CORP c/o Intertrust Corporate Services (Cayman) Limited 190 Elgin Avenue George Town, Grand Cayman KY1-9005 Cayman Islands April 8, 2020 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Stealth BioTherapeutics Corp Registration Statement on Form F-3 File No. 333-237542 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Stealth BioTherapeutics Corp hereby requests acceleration of the effective date of its Registration Statement on Form F-3 (File No. 333-237542), so that it may become effective at 4:00 p.m., Eastern time, on April 10, 2020, or as soon as practicable thereafter. Very truly yours, STEALTH BIOTHERAPEUTICS CORP By: /s/ Irene P. McCarthy Name: Irene P. McCarthy Title: Chief Executive Officer